For context, GLP-1s are only FDA-approved for people whose BMI is at least 30, or for people with a BMI of 27 and who have a weight-related health condition
Madsbad S, Kielgast U, Asmar M, Deacon CF, Torekov SS, Holst JJ
There are discussions about using these drugs in overweight individuals (BMI 2730) to prevent progression to obesity or to treat weight-related conditions even at lower BMI, but currently insurance coverage is mainly for obesity or diabetes
This timeframe balances practical portabilityallowing patients to travel or keep medications at their workplacewith safety margins that ensure the compound remains chemically stable
While no studies have been conducted on pregnant people taking GLP-1 drugs, studies in animals such as rats, rabbits, and monkeys showed that these animals experienced high rates of miscarriages when they were given an injectable GLP-1 medication
These are tiny tubes (like blood vessels) that carry lymphatic fluid to and from your lymph nodes